Company / Interest Expense
Foghorn Therapeutics Inc. Interest Expense History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$979.0K
FY2021
5-year range
$979.0K / $979.0K
FY2020-FY2021
Trend
+81.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$979,000 in FY2021.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense increased 81.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $979.0K | +81.3% |
| FY2020 | $540.0K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026